Refine Search
(4)
(28)
(74)
(75)

Retinoblastoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H2 2018’, provides an overview of the Retinoblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinoblastoma, ...

Rhabdomyosarcoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2018’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rhabdomyosar...

Hairy Cell Leukemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2018’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hairy ...

Ureter Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H2 2018’, provides an overview of the Ureter Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ureter Cancer, com...

Uveal Melanoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H2 2018’, provides an overview of the Uveal Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, ...

Oligodendroglioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2018’, provides an overview of the Oligodendroglioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Oligodendr...

Thyroid Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thyroid Cancer - Pipeline Review, H2 2018’, provides an overview of the Thyroid Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thyroid Cancer, ...

Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018’, provides an overview of the Cancer Anorexia-Cachexia Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Esophageal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2018’, provides an overview of the Esophageal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Esophageal...

Malignant Mesothelioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2018’, provides an overview of the Malignant Mesothelioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Ependymoma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ependymoma - Pipeline Review, H2 2018’, provides an overview of the Ependymoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ependymoma, complete wit...

Hypopharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypopharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Hypopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hy...

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018’, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline landscape.

The report provides comprehensive informat...

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

The report provides comprehensive information on...

Polycythemia Vera - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2018’, provides an overview of the Polycythemia Vera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Polycythem...